| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 45.267 | 74.416 | 72.001 | 83.342 | 93.642 |
| Total Income - EUR | - | - | - | - | - | 48.368 | 74.416 | 72.006 | 83.343 | 93.645 |
| Total Expenses - EUR | - | - | - | - | - | 15.009 | 34.671 | 42.466 | 37.249 | 47.788 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 33.359 | 39.746 | 29.541 | 46.094 | 45.857 |
| Net Profit/Loss - EUR | - | - | - | - | - | 32.906 | 39.002 | 28.833 | 45.301 | 43.048 |
| Employees | - | - | - | - | - | 2 | 3 | 3 | 3 | 2 |
Check the financial reports for the company - Danovi - Telmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 2.555 | 2.123 | 2.330 | 1.709 |
| Current Assets | - | - | - | - | - | 36.600 | 38.815 | 31.862 | 47.349 | 49.588 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 25.739 | 14.431 | 14.497 | 26.563 | 32.122 |
| Cash | - | - | - | - | - | 10.862 | 24.384 | 17.364 | 20.786 | 17.466 |
| Shareholders Funds | - | - | - | - | - | 32.989 | 39.117 | 29.139 | 45.442 | 47.311 |
| Social Capital | - | - | - | - | - | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | - | - | 3.611 | 2.253 | 4.847 | 4.237 | 3.985 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Danovi - Telmed S.r.l.